ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)
|
|
|
- Jean Oliver
- 5 years ago
- Views:
Transcription
1 ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Phone: (303) Always identify any medications/drugs the suspect states they have taken, or that you suspect they have taken, in the "Medications Taken" Area. For drugs that are not included in a screening panel, check the "Other" box and write in the specific drug/drug screen you would like to request. "Qualitative only" compounds will be reported as positive or negative. (Drug names listed in bold have testing that has been updated or added) Drug Name (Generic) Brand/Common Names ELISA Screening Group Panel "Other" Request Confirmation Method Notes 6- Monoacetylmorphine 6- MAM (Heroin Metabolite) Opiates 5,7,11 GC/MS Qual only Aerosols Duster, Hairspray, PAM Toxic Vapors GC- FID Qual only Alprazolam Xanax Benzodiazepines 5,7,11 LC- MS/MS Amitriptyline Hydrochloride Elavil, Endep, Levate Tricyclic Antidepressants GC/MS Amphetamine Adderall, Dextroamphetamine Amphetamine/MDA LC- MS/MS Benzoylecgonine BE (Cocaine metabolite) Cocaine 5,7,11 GC/MS Qual only Buprenorphine Subutex, Suboxone Buprenorphine GC/MS Butalbital Fioricet, Bupap Barbiturates 11 LC- MS/MS Bromazepam Benzodiazepines 5,7,11 LC- MS/MS Screen only Carbon Monoxide CO UV- VIS Carisoprodol Soma, Carsodol Carisoprodol 11 LC- MS/MS Chlordiazepoxide Librax, Librium, Limbitrol Benzodiazepines 5,7,11 LC- MS/MS Chlorpheniramine Chlor- Tabs, Aller- Chlor, Teldrin LC- MS/MS LC- MS/MS Citalopram Celexa Citalopram GC/MS Clonazepam Klonopin, Quanapin LC- MS/MS* LC- MS/MS Cocaethylene Cocaine 5,7,11 GC/MS Cocaine Crack, Coke Cocaine 5,7,11 GC/MS Codeine Codapap, Tylenol 3/4, Cotab Opiates 5,7,11 GC/MS Cyclobenzaprine Flexeril, Amrix Tricyclic Antidepressants GC/MS Delta- 9- THC Marijuana, THC, Hashish Cannabinoids 7,11 LC- MS/MS *Levels too low for Benzo screen
2 11- nor- 9- Carboxy- THC Carboxy THC (inactive metabolite) Cannabinoids 7,11 LC- MS/MS Qual only 11- Hydroxy- THC Hydroxy THC (active metabolite) Cannabinoids 7,11 LC- MS/MS Dextromethorphan DXM, DM, Robo GC Scan GC/MS Diacetylmorhine* Heroin Opiates 5,7,11 GC/MS Diazepam Valium Benzodiazepines 5,7,11 LC- MS/MS Diphenhydramine Benadryl, Tylenol PM, Dramamine, Sominex GC Scan LC- MS/MS Doxepin Adapin, Sinequan Tricyclic Antidepressants GC/MS Doxylamine Unisom GC Scan LC- MS/MS Dronabinol Marinol Cannabinoids 7,11 LC- MS/MS Escitalopram Lexapro Citalopram GC/MS *Reported as 6- MAM & Morphine Estazolam Benzodiazepines 5,7,11 LC- MS/MS Screen only Ethanol Alcohol GC- FID Fentanyl Sublimaze, Duragesic Fentanyl GC/MS Flurazepam Dalmane Benzodiazepines 5,7,11 LC- MS/MS Screen only Hydrocodone Vicodin, Norco, Lortab Opiates 5,7,11 GC/MS Hydromorphone Dilaudid, Exalgo, drug- store heroin Opiates 5,7,11 GC/MS Hydroxyzine Vistaril, Atarax LC- MS/MS LC- MS/MS Qual only Ketamine Ketaved, Ketaset, Vetamine, Special K Ketamine GC/MS Lorazepam Ativan LC- MS/MS* LC- MS/MS *Levels too low for Benzo screen Lormetrazepam Benzodiazepines 5,7,11 LC- MS/MS Screen only MDA (MDMA metabolite) Amphetamine/MDA LC- MS/MS MDEA LC- MS/MS MDMA Ecstacy Methamphetamine/MDMA 5,7,11 LC- MS/MS Meperidine Demerol GC Scan GC/MS Meprobamate Miltown, Equanil, (Carisoprodol metabolite) Carisoprodol 11 LC- MS/MS Methadone Methadose, Dolophine Methadone 11 GC/MS
3 Methamphetamine Crystal meth, speed, ice Methamphetamine/MDMA 5,7,11 LC- MS/MS Midazolam Versed Benzodiazepines 5,7,11 LC- MS/MS Mirtazepine Remeron GC Scan GC/MS Morphine Avinza, MS Contin, Oramorph SR, Roxanol (Heroin metabolite) Opiates 5,7,11 GC/MS Nitrazepam Benzodiazepines 5,7,11 LC- MS/MS Screen only Nordiazepam (Diazepam metabolite) Benzodiazepines 5,7,11 LC- MS/MS Nortriptyline (Amitriptyline metabolite) Tricyclic Antidepressants GC/MS Oxazepam Serax Benzodiazepines 5,7,11 LC- MS/MS Oxycodone Oxycontin, Percocet, Roxicodone, Endocet Oxycodone 7,11 GC/MS Oxymorphone Opana, Numorphan Oxycodone 7,11 GC/MS Phencyclidine PCP GC Scan GC/MS Phenobarbital Luminal Barbiturates 11 LC- MS/MS Phenytoin Dilantin, Diphenylhydantoin LC- MS/MS LC- MS/MS Promethazine Prothiazine, Phenergan GC Scan GC/MS Quetiapine Seroquel GC Scan GC/MS Secobarbital Seconal Barbiturates 11 LC- MS/MS Tapentadol Nucynta GC Scan GC/MS Temazepam Restoril Benzodiazepines 5,7,11 LC- MS/MS Toxic Vapors (Toluene, Polyfluorinated Ethanes) Paint, dust- off Toxic Vapors GC- FID Qual only Tramadol Ultram, Tramal Tramadol 11 GC/MS Trazodone Desyrl GC Scan GC/MS Triazolam Benzodiazepines 5,7,11 LC- MS/MS Screen only Volatiles (Acetone, Hexanes, Methanol, Isopropanol) Plastic cement, glue GC- FID Qual only Zolpidem Ambien Zolpidem 5,7,11 LC- MS/MS
4 ChemaTox Reference Laboratory Compounds Screening and/or confirmation testing on the following drugs is offered through one of our approved reference laboratories, as indicated below. This list is not comprehensive. Please contact ChemaTox with any specfic questions regarding capabilities and costs of reference laboratory testing. Drug Category Benzodiazepines "Z" Drugs Hallucinogens Neuroleptics Other Drugs Included Clobazam, Estazolam, Flurazepam, Triazolam Zopiclone, Zaleplon Psilocin, LSD- 25, Mescaline Gabapentin, Pregablin Synthetic Cannabinoids, Bath Salts, Psychedelic Phenethylamines Laboratory or NMS or NMS To discuss requests for drugs not listed in this document, please don't hesitate to contact us at or (303) By: Lauren Wiles, B.A. and Sarah Urfer, M.S.
5
Urine Opioid Dependency Panel (UODP) 1
Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,
Prescription Drug Monitoring Reference Guide: 2017
Prescription Drug Monitoring Reference Guide: 2017 Prescription Drug Monitoring Test Codes Test Codes Drug/Drug Class P P,D,M P,D D,M D Alcohol Metabolites 90079 16910 92142 16217 Amphetamines 92222 70245
Forensic Toxicology Scope of Testing and Detection Limits
Forensic Toxicology Scope of Testing and Detection Limits Table of Contents QUALITATIVE ANALYSES... 2 Volatile Screen by GC/FID... 2 Carbon Monoxide by Microdiffusion... 2 Ethylene Glycol by GC/MS... 2
Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX
Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing
Physician s Reference for Urine and Blood Drug Testing and Interpretation
Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine
1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia
NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.
Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: HYDROMORPHONE (DILAUDID, EXALGO), CYCLOBENZAPRINE (FLEXERIL), METHADONE (METHADOSE),
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE, MARYLAND QUARTERLY REPORT: FOURTH QUARTER, 2008 AND 2008 SUMMARY A report from the Office of Epidemiology and Planning Baltimore
Urine Drug Testing Methods 3-5
Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry
INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY
2009 FINAL REPORT INTOXICATION DEATHS ASSOCIATED WITH DRUGS OF ABUSE OR ALCOHOL BALTIMORE CITY This report was prepared by: Dr. Jose Arbelaez, M.D. of Baltimore Substance Abuse Systems, and Ryan J. Petteway,
Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082
Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending
Prescription Drug Abuse: Colorado and Nationwide
Prescription Drug Abuse: Colorado and Nationwide Eric Lavonas, MD Associate Director, Rocky Mountain Poison and Drug Center Associate Professor, University of Colorado School of Medicine 1 What s the Problem?
1. Amphetamine (Adderall, desoxyn, Dexedrine,dextrostat, spancap, oxydess II)
Cross reactivity of various pharmaceuticals against the Drugs of Abuse Screening Panel (posted 2/3/09) The following tables are only applicable to the specific analyzer and reagents used at HRHS main lab.
LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching
Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple
Tests recently added to the NMS Labs test menu. New Tests are effective immediately.
Modified Date: 01/12/2012 In our continuing effort to provide you with the highest quality toxicology laboratory services available, we have compiled important changes regarding a number of tests we perform.
CNS DEPRESSANT OVERDOSE
Signs and symptoms of CNS depressant overdose include: altered mental status, respiratory depression, hypotension, bradycardia, pulmonary edema, coma, and constricted pupils (opioids only). The following
PARTICIPANT GENERAL INFORMATION
PARTICIPANT GENERAL INFORMATION Instructions: Please complete entire form (print) First name: Last Name: Other names used: Street address: City/State/Zip: County: Region: East TN Middle West Social Security
OTHER DRUGS OF ABUSE Source:
Volume 6, Number 4 APRIL - JUNE, 2017 This newsletter is provided by the Lorain County Crime/Drug Lab discussing technical and general information dedicated to local agencies within Lorain County. The
Pain Medication Management Program Supports Patient Outcomes and Adherence
PeaceHealth Laboratories UPDATE 2015 Revised Edition Pain Medication Management Program Supports Patient Outcomes and Adherence BENEFITS Monitors analgesic medication adherence to ensure patient safety
Xyrem (Sodium Oxybate)
Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
Opiate/Benzodiazepine/Muscle Relaxant Combinations
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Opiate/Benzodiazepine/Muscle Relaxant Combinations Clinical Edit Information Included in this Document Drugs requiring prior authorization:
3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years
Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG
Drugs Found in Medical Examiner Cases
s Found in Medical Examiner Cases 1,1 difluoroethane propellant in aerosols 10-Hydroxycarbazepine 11-Hydroxy Delta-9 THC 6-monoacetylmorphine 7-amino clonazepam acetaminophen acetone alpha-hydroxyalprazolam
Pain Medication Management Program Monitors Patient Compliance
PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your
September HCMC Toxicology Transition: Additional information and Frequently Asked Questions
September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch
Texas Prior Authorization Program Clinical Edit Criteria
Texas Prior Authorization Program Clinical Edit Criteria Drug/Drug Class Clinical Edit Information Included in this Document Drugs requiring prior authorization: the list of drugs requiring prior authorization
Test Definition: PCDSO Pain Clinic Drug Screen, Urine
Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle
Cross-reactivity reactivity in EMIT
Blood Drug Analysis at the State Bureau of Investigation Crime Laboratory Richard W. Waggoner, Jr. Sample Requirements 2-10 ml gray top vacutainers At least 10 ml of urine sample for drug facilitated sexual
Pinellas County Forensic Laboratory. Annual Report 2006
Pinellas County Forensic Laboratory Annual Report 26 Published April 27 Analytical Services Provided Post Mortem/Medical Examiner Toxicology Seized Drug (Controlled Substances) Analysis Fire Debris and
What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital
What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.
The Drug Testing Process. Employer or Practice
Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine
Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine
Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and
! Drug Screen Quick Reference Guide
AMPHETAMINE (AMP) Amphetamines are central nervous stimulants whose effects include alertness, wakefulness, increased energy, reduced hunger and an overall feeling of well being. Large doses and long term
Drug Adherence Assessment Report
Prescribed Medications: Drug Adherence Assessment Report FENTANYL, OXYCODONE CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED ANTICIPATED TEST PRESCRIPTION (S)
Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids
PO-CON1753E Fully Automated Online Sample Preparation and LC-MS/MS Analysis of Drugs of Abuse in Oral Fluids ASMS 2017 TP-442 Joshua F. Emory 1, Nathan DeFreitas 2, Michael Roberts 1, Manoj Tyagi 2, M.
CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva)
CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) Cat. No.: DTSJZ023 Pkg. Size: Intended Use The CDIA TM Marijuana Colloidal Gold Test Cassette (Saliva) is an immunochromatography based one step
nextgen precision Test Report
nextgen precision TM Test Report SUMMARY OF PRECISION S NEXTGEN TEST REPORT In an effort to provide as much clinical insight as possible to our providers, we created our comprehensive NextGen Precision
Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens
Validation Report for the Neogen Fentanyl Kit for ELISA Screening of Whole Blood and Urine Specimens This document describes the validation of a Neogen Fentanyl kit for the semi-quantitative analysis of
Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations. Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K.
Evaluation of the Impact of Expanding ELISA Screening in DUID Investigations Aileen Lu*, Karen S. Scott, Aya Chan-Hosokawa, and Barry K. Logan FSF Emerging Forensic Scientist Award Oral Presentation Disclosure
DrugSmartCup & DrugSmartDip Accuracy Report as produced by Ameditech, Inc.
Accuracy The accuracy of the DrugSmart Drugs of Abuse Tests was evaluated in comparison to commercially available drug screen tests. Sixty (60) negative urine samples collected from presumed non-user volunteers
ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS
ORAL FLUID AS A CHEMICAL TEST FOR THE DRE PROGRAM : HISTORY, THE FUTURE, AND PRACTICAL CONSIDERATIONS Barry K Logan PhD, DABFT National Director of Forensic Services, NMS Labs Willow Grove PA Disclaimer
PAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
Drugs of Abuse I Serum
Drugs of Abuse I Serum 2017-11 1.10 For quality monitoring of quantitative measurements by chromatographic methods These reference materials are produced on the basis of human matrices. The highly accurate
Laboratory Service Report
4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric
May Revised Urine Drug Screen Test Menu Effective mid-june Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory
May 2014 Lauren Anthony, MD, MT(ASCP) SBB Medical Director, Allina Health Laboratory Revised Urine Drug Test Menu Effective mid-june 2014 To better address the complexities of drug screening for different
Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey
Toxicological Investigation of Drug Impaired Driving Toxicology Laboratory Survey Kayla J. Lowrie, MS, Jennifer Turri, BS, Jill Yeakel, MSFS, Barry K. Logan, PhD, DABFT, Arcadia University, 450 S. Easton
Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.
Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory Lyndsey.Knoy@wsp.wa.gov Forensic Toxicology is an interdisciplinary science that analyzes blood, fluid and/or tissues for
Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, PM
Caring for ME Webinar: Urine Drug Screening Speaker: Dr. Jonathan Fellers Tuesday, November 20, 2018 12 1 PM Audio is available through your computer speakers. Mission Maine Quality Counts is a nonprofit
Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)
1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory
LC Application Note. Dangerous driver?
LC Application Note Dangerous driver? www.palsystem.com Dangerous driver? Robert M. Sears 1 ; Kenneth C. Lewis 2 ; and Kim Gamble 3 1 SC Law Enforcement Division, Columbia, SC 29221; 2 OpAns LLC, Durham
2015 Annual Physician Notice
0 Annual Physician Notice The Office of Inspector General (OIG) recommends clinical laboratories send notices to physicians and other providers who use their services, at least once a year, to inform the
Welcome to LabSolutions, LLC
Welcome to LabSolutions, LLC Upon requesting our services, we will supply Specimen Transport Cups, Bio Bags, UPS Lab Paks, UPS Shipping Labels, Test Requisition Forms, and Patient Acknowledgement Forms.
Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab
Application Note Clinical Research Rapid LC/TOF MS for Analytical Screening of Drugs in the Clinical Research Lab Authors Adam Barker 1,2, Frederick G. Strathmann 3, Natalie N. Rasmussen 4, and Carrie
SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2007) Substance Use Disorders E. 2
SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2007) Substance Use Disorders E. 2 *LIFETIME ALCOHOL ABUSE* Let me ask you a few more questions about (TIME WHEN DRINKING THE MOST OR TIME WHEN DRINKING CAUSED
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies
Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies Frederick G. Strathmann, PhD, DABCC, (CC,TC) Medical Director, Toxicology Associate Scientific Director of MS ARUP Laboratories
Common Drugs of Abuse. What to look for, physical symptoms, and dangers
Common Drugs of Abuse What to look for, physical symptoms, and dangers We lead the industry in science and service. By choosing Quest Diagnostics Employer Solutions as your drug testing partner, you gain
Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS
Validation of a Benzodiazepine and Z-Drug Method Using an Agilent 6430 LC/MS/MS Application Note Forensics Authors Jason Hudson, Ph.D., James Hutchings, Ph.D., and Rebecca Wagner, Ph.D. Virginia Department
Opioids: Use, Abuse and Cause of Death. Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory
Opioids: Use, Abuse and Cause of Death Jennifer Harmon Assistant Director - Forensic Chemistry Orange County Crime Laboratory jharmon@occl.ocgov.com Opioid: Any psychoactive chemical that resembles morphine
Welcome - SAMHSA s Role. Welcome SAMHSA Key Messages 4. Welcome SAMHSA s Direction
Welcome - SAMHSA s Role 2 Welcome and Opening Remarks The National Conference on Substance Abuse, Child Welfare and the Courts Division of Workplace Programs Ron R. Flegel, BSMT, M.S. and Charles Lodico,
INTRODUCTION. Area Description
Recent Drug Abuse Trends in the Seattle-King County Area Caleb Banta-Green 1, T. Ron Jackson 2, Michael Hanrahan 3, Susan Kingston 3, David H. Albert 4, Steve Freng 5, Ann Forbes 6, Richard Harruff 7,
Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples
Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples Robert M. Sears, Toxicology Technical Leader 1, Kenneth
Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.
Applications of High Resolution Mass Spectrometry in Forensic Toxicology Patrick Kyle, PhD pkyle@umc.edu Financial Disclosures Grant/Research Support: None Salary/Consultant Fees: None Board/Committee/Advisory
E XCEL LENCE JUST GOT BETTER UCT FORENSICS CLEAN SCREEN XCEL SPE COLUMNS
FORENSICS UCT E XCEL LENCE JUST GOT BETTER CLEAN SCREEN XCEL SPE COLUMNS CLEAN SCREEN XCEL COLUMNS EXTRACTION OF BASIC DRUGS AND METABOLITES FROM URINE/ BLOOD USING SPE CARTRIDGES 130mg Clean Screen Xcel
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population
Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,
More than pain: unintended consequences of chronic pain treatment
More than pain: unintended consequences of chronic pain treatment Marianne Cumming, BSc (Pharm), MSc, MD, DBIM, FALU Senior Vice President, Head Global Life & Health Underwriting January 30, 2017 Table
[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS
![[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS](/thumbs/87/95409880.jpg "[ APPLICATION NOTE ] APPLICATION BENEFITS INTRODUCTION WATERS SOLUTIONS KEYWORDS")
A Comprehensive Method for the Analysis of Pain Management Drugs and Drugs of Abuse Incorporating Simplified, Rapid Mixed-Mode SPE with UPLC-MS/MS for Clinical Research Jonathan P. Danaceau, Scott Freeto,
Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.
Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals
Urine drug testing it s not always crystal clear
Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine
20/0.8mg, 30/1.2mg, Films 90 MME/day Belbuca (buprenorphine) 75mcg, 150mcg, 300mcg, 450mcg 60 units per 90 days
Pre - PA Allowance Quantity Extended Release Tablets or Capsules 90 MME/day Medication Strength Avinza (morphine) 60mg, 75mg, 90mg Embeda (morphine /naltrexone) 50/2mg, 60/2.4mg, 80/3.2mg Exalgo (hydromorphone)
INTERPATH LABORATORY, INC. TEST UPDATES
EFFECTIVE DATE: February 16, 2016 INTERPATH LABORATORY, INC. TEST UPDATES Please take note of the following test updates and make the appropriate changes in your Interpath Service Manual. Feel free to
Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview
Analysis of Benzodiazepines in Alternate Matrices by HPLC. Overview Benzodiazepines/Class/Structure Benzodiazepine Metabolism/Elimination Biological Specimens Instrumentation Analytical Method Controls
FLORIDA DEPARTMENT OF LAW ENFORCEMENT MAY 2014
FLORIDA DEPARTMENT OF LAW ENFORCEMENT MAY 2014 Data Collection The State of Florida s Office of Vital Statistics reported more than 94,000 deaths occurred in Florida during the first six months of 2013.
DOF. Scheme Description. Drugs in Oral Fluid Scheme
DOF Drugs in Oral Fluid Scheme Scheme Description LGC Standards Proficiency Testing 1 Chamberhall Business Park Chamberhall Green Bury Lancashire BL9 0AP United Kingdom Telephone: +44 (0) 161 762 2500
Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies
Procedure: Status DS Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature Distributed to # of Copies Distributed to # of Copies PRINCIPLE: The Status DS 10 Panel (MET/OPI/COC/THC/PCP/BZO/BAR/MTD/TCA/AMP)
SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2007) Substance Use Disorders Alt-E. 2
SCID-I (for DSM-IV-TR) Alcohol Abuse (JAN 2007) Substance Use Disorders Alt-E. 2 *LIFETIME ALCOHOL ABUSE* IF DEFINITE PERIOD: Let me ask you a few more questions about (TIME WHEN DRINKING THE MOST OR HAD
Drug Trends &Trafficking I/S Brian Dempsey
Drug Trends &Trafficking I/S Brian Dempsey 412-777-6945 brian.w.dempsey@usdoj.gov Sources Sources 360 Degree Strategy Strategic collaboration and guidance via three interconnected avenues. Community
Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization
Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation
A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography
Application Note LCMS-109 A Simple and Accurate Method for the Rapid Quantitation of Drugs of Abuse in Urine Using Liquid Chromatography Time of Flight (LC-TOF) Mass Spectrometry Introduction Many clinical
Patient Instructions
Patient Instructions Appointment Information A telephone intake appointment will be scheduled prior to your first scan. During this call, our clinician will go over your completed paperwork and may ask
Drug Testing Basics. by Erowid
Drug Testing Basics by Erowid INDEX 1. What do they Test for? 2. Test Types 3. Test Sensitivity 4. Detection Periods WHAT DO THEY TEST FOR? The first thing to know about drug testing is what the standard
10/9/18. Learning Objectives. Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization
Get Your Specimens in Order: The Importance of Individualized Test Orders and Timely Test Utilization Prepared and presented by Jennifer Bolen, JD Disclosures for Jennifer Bolen, JD Consultant - Generation
Prescription Drug Dispensing in Oregon
Drug Dispensing in Oregon January 1, 2012 - December 31, 2012 Schedules II-IV Medications Dispensed in Oregon Linn County PUBLIC HEALTH DIVISION Drug Monitoring Program Drug Dispensing in Oregon: January
Drug Screening. Separating Facts from Myths
Drug Screening Separating Facts from Myths Today s Presenter: Todd Shoulberg, EVP ClearStar Medical Information Services Todd Shoulberg, Executive Vice President of Medical Information Services for ClearStar,
European Guidelines for Workplace Drug Testing in UrineandOral fluid
EWDTS European Workplace Drug Testing Society European Guidelines for Workplace Drug Testing in UrineandOral fluid 9th EWDTS Symposium in Lisbon Sanna Taskinen Michaela Neuhofer Updating project # 2 Current
Dynacare Laboratories
Dynacare Laboratories Affiliated with Froedtert & the Medical College of Wisconsin January 2015 2015 CPT Code Updates Dear Client: The American Medical Association (AMA) publishes the Current Procedural
Validation of an Automated Method to Remove
Shahana Wahab Huq 1, Richard Thomas 2, Agnes Cua 2, Seyed Sadjadi 1 1 Phenomenex, 411 Madrid Avenue, Torrance, CA 951 2 Precision Toxicology, 33 Bunker Hill Street, San Diego, CA 9219 Validation of an
Appendix: Psychotropic Medication Reference Tables
Appendix: Psychotropic Medication Reference Tables How to Use these Tables These reference tables are designed to provide clinic staff with specific medication related criteria for the Polypharmacy, Cardiometabolic
ToxCup Drug Screen Cup Step-by Step Instructions
ToxCup Drug Screen Cup Step-by Step Instructions This is a preliminary screening test that detects drug-of-abuse in urine at specified detection levels. To confirm preliminary positive results, a more
Have You Ever Wondered
Have You Ever Wondered A few facts about medication use and related falls The Number of Medications You Take & The Connection to Falls CONCERN: As you increase the number of medications that you take,
Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK
Schedule of ccreditation United Kingdom ccreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK ccredited to Laboratory locations: Gavenny Court Brecon Road bergavenny Monmouthshire
1/29/2013. Schedule II Controlled Substances: Basics and Beyond. Controlled Substances. Controlled Substances, Schedule I
chedule II Controlled ubstances: Basics and Beyond James L. Besier, Ph.D., R.Ph., FAHP Adjunct Associate Professor College of Nursing Adjunct Assistant Professor James L. Winkle College of Pharmacy University
METHAMPHETAMINE & AMPHETAMINE
METHAMPHETAMINE & AMPHETAMINE Enantiomers from Urine Rapid and Accurate Chiral Separation Polysaccharide Chiral Chiral LC LC Columns and SFC PHEN-RUO-49 Revision: Lux 3 µm AMP Column High Efficiency LC/MS/MS
CAN MY DRUG SCREEN BE WRONG?
CAN MY DRUG SCREEN BE WRONG? Drug screens performed for compliance monitoring or as an initial step before prescribing opioids can have several sources of errors. One of the most frequent sources of error
Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System
Rapid and Sensitive Analysis of a 93-Compound Forensic Panel in Urine using the QTRAP /Triple Quad 4500 LC- MS/MS System Xiang He, 1 Casey Burrows 1, Matthew Noestheden 2, Michael Jarvis, 2 Adrian Taylor,
National 800 Phone Number. What is Misuse? Iowa s PCC. Commonly Misused Rx Drugs. Pharmageddon: The Rx Drug Abuse Crisis 04/07/14 1
Pharmageddon: The Rx Drug Abuse Crisis National 800 Phone Number Works just like 911 Program your cell phone! Linda B. Kalin, RN, BS, CSPI Director Linda.Kalin@unitypoint.org Hotline: 800-222-1222 Office:
CARD TOBACCO: Cigarettes, E- Cigarettes, Cigars, Tobacco Pipe, Chewing Tobacco, Snuff
CARD 1 1. TOBACCO: Cigarettes, E- Cigarettes, Cigars, Tobacco Pipe, Chewing Tobacco, Snuff 2. ALCOHOL: Beer, Wine, Liquor 3. MARIJUANA: Grass, Pot, Hashish, Hash, Hash Oil, Weed, Ganja, Marijuana Edibles
Section 2 Class III, IV & V Pharmaceuticals Page 13
Section 2 Class III, IV & V Pharmaceuticals Page 13 ACETAMINOPHEN W/ CODEINE #3 30MG TABS (GENERIC TYLENOL) #100 41.99 ACETAMINOPHEN W/ CODEINE #3 30MG TABS #1000 298.99 ACETAMINOPHEN W/ CODEINE #4 60MG
ADMISSION INTRACTABLE PAIN PROGRAM
DMISSION INTRCTBLE PIN PROGRM INSTRUCTIONS TO PTIENT: Please complete this form to apply to our intractable pain program. USE BLCK INK ONLY! I. BSIC DT Today's Patient's Name Date Last First Phone ddress
Urine Drug Screening: The Essentials of Interpretation
Urine Drug Screening: The Essentials of Interpretation Loralie J Langman, PhD DABCC (CC, MD, TC), F-ABFT Director Clinical and Forensic Toxicology Laboratory, Mayo Clinic Professor, Mayo Clinic College